Financial statements Inpharm
Cash flow statement of Inpharm
Company age:
Age:
19 y. 6 m. 10 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of INPHARM
|
Year
|
2022
|
2023
|
|---|---|---|
| Net cash from operating expenses | -336,00 | 1 710,00 |
| Net cash flow from investing activities | -534,00 | -487,00 |
| Net cash flow from financial activities | 1 040,00 | -1 256,00 |
| Total net cash flow | 170,00 | -33,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.